Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
14970-87-7
17643-17-3
88778-21-6
50741-53-2 | 6-Hydroxy-2-methylquinoline-4-carboxylic acid | AA00DEJ2 | MFCD00459572
55215-18-4 | 2,2',3,3',4,5-HEXACHLOROBIPHENYL | AA00DEPV | MFCD00152532
4684-28-0 | [7(S)-(1alpha,.2beta,4beta,5alpha,7beta)]-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate | AA00DEWT | MFCD22666251
537693-29-1 | 11-Keto Oxcarbazepine | AA00DF3P | MFCD24386459
4338-98-1 | 2-Hydrazono-3-methyl-2,3-dihydrobenzo[d]thiazole hydrochloride | AA00DF9Y | MFCD00149370
518990-35-7 | 5-Ethoxy-1h-indazole | AA00DFH0 | MFCD08059262
52249-48-6 | Methyl 2-(quinolin-2-yl)acetate | AA00DFNP | MFCD08700388
50548-43-1 | 4-Dibenzofuranamine | AA00DFYG | MFCD11110988
479630-02-9 | tert-Butyl 4-(3-methoxy-3-oxopropanoyl)piperidine-1-carboxylate | AA00DGAD | MFCD11974569
4746-61-6 | 2-Hydroxy-n-phenylacetamide | AA00DGRN | MFCD00068778
